| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/18/2007 | US20070243226 Growth factor complex |
| 10/18/2007 | US20070243213 Hbv Variants Detection and Application |
| 10/18/2007 | US20070243208 Novel chimeric protein for prevention and treatment of hiv infection |
| 10/18/2007 | US20070243207 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 10/18/2007 | US20070243206 Using hybrid fibrin peptides to prevent hemophilus infection |
| 10/18/2007 | US20070243205 Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus |
| 10/18/2007 | US20070243204 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 10/18/2007 | US20070243203 HIV polypeptide and polynucleotide fusions of Gag, Pol and Nef; AIDS; purifying the fusion polypeptide; carboxyamidation |
| 10/18/2007 | US20070243202 Tumor necrosis factor receptor-associated factors |
| 10/18/2007 | US20070243201 Method for Selecting Epitopes for Immunotherapy |
| 10/18/2007 | US20070243198 Production of biologically active proteins |
| 10/18/2007 | US20070243197 Dendrite Cells Transduced with Recombinant Adenovirus Advcea Which Generate Cea-Specific Cytotoxic T Lymphocytes, Vaccine and Pharmaceutical Composition Comprising the Same |
| 10/18/2007 | US20070243190 Receptor-mediated uptake of an extracellular bcl-xl fusion protein inhibits apoptosis |
| 10/18/2007 | US20070243188 Fc Variants Having Decreased Affinity for FcyRlla |
| 10/18/2007 | US20070243176 Human genes and gene expression products |
| 10/18/2007 | US20070243167 Novel Herpes Simplex Viruses |
| 10/18/2007 | US20070243165 Granulocyte colony stimulating factor obtained from eggs laid by transgenic avians having newly described G-CSF glycosylation patterns; gene expression of exogenous proteins |
| 10/18/2007 | US20070243164 Treating Skin Cancer |
| 10/18/2007 | US20070243139 A dimer of two polypeptides having specificity andreceptivity for different epitopes on a protein-tyrosinekinase receptor; linked by spacers; synergistic; contrast agents for radition imaging and therapy; biodrugs; hepatocyte growth factor receptor/cMET complex target; antitumor, -carcinogenic agents |
| 10/18/2007 | DE10045123B4 Das C. albicans TEC1 GEN(CaTEC1) und das kodierte Tec1p Protein The C. albicans TEC1 GEN (CaTEC1) and the encoded protein Tec1p |
| 10/18/2007 | DE10023130B4 Hyphenspezifische Faktoren aus Candida albicans Hyphenspezifische factors of Candida albicans |
| 10/18/2007 | CA2649364A1 The homeobox transcription factor bsx and uses thereof for treating diseases, in particular obesity |
| 10/18/2007 | CA2649199A1 Method of increasing the in vivo recovery of therapeutic polypeptides |
| 10/18/2007 | CA2648718A1 Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency |
| 10/18/2007 | CA2648557A1 A group of novel enantioselective microbial nitrile hydratases with broad substrate specificity |
| 10/18/2007 | CA2647907A1 Use of tm-601 for the diagnosis and treatment of tumors |
| 10/18/2007 | CA2647271A1 Binder for c-reactive protein |
| 10/18/2007 | CA2647125A1 Synthetic mecp2 sequence for protein substitution therapy |
| 10/18/2007 | CA2646900A1 Hypoallergenic chimeric proteins belonging to the lipid transfer family of parietaria judaica for use in the treatment of allergies |
| 10/18/2007 | CA2642721A1 Purification of bacterial antigens |
| 10/18/2007 | CA2638864A1 Truncated il-17ra soluble receptor and methods of using in inflammation |
| 10/18/2007 | CA2638778A1 Clay-binding peptides and methods of use |
| 10/18/2007 | CA2616859A1 Compositions and methods for production of immunoglobulins |
| 10/17/2007 | EP1845164A2 Promoters for expression in modified vaccinia virus ankara |
| 10/17/2007 | EP1845163A2 Adeno-associated virus serotype l nucleic acid sequences, vetors and host cells containing same |
| 10/17/2007 | EP1845162A1 DNA sequences having anti-repressor activity |
| 10/17/2007 | EP1845159A1 Method of determining gene relating to favorable beef taste and texture |
| 10/17/2007 | EP1845108A2 Monoclonal antibodies to purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 10/17/2007 | EP1845107A2 RGD-enriched gelatine-like proteins with enhanced cell binding |
| 10/17/2007 | EP1845106A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 10/17/2007 | EP1845105A1 Modified exendins and uses thereof |
| 10/17/2007 | EP1844798A1 Implantable putty material |
| 10/17/2007 | EP1844790A2 Using a reverse genetic engineering platform to produce protein vaccinces and protein vaccine of avian influenza virus |
| 10/17/2007 | EP1844337A1 Binding compounds, immunogenic compounds and peptidomimetics |
| 10/17/2007 | EP1844322A2 Methods of identification of biomarkers with mass spectrometry techniques |
| 10/17/2007 | EP1844152A2 Production of antibodies in plants with plus-sense single-stranded viral rna vectors |
| 10/17/2007 | EP1844149A1 Screening method |
| 10/17/2007 | EP1844074A2 Human antibodies and proteins |
| 10/17/2007 | EP1844072A1 Mhc oligomer and method of making the same |
| 10/17/2007 | EP1844071A2 Cell adhesion by modified cadherin molecules |
| 10/17/2007 | EP1844070A1 Peptides with neuropeptide-2 receptor (y2r) agonist activity |
| 10/17/2007 | EP1844069A1 Molecules and chimeric molecules thereof |
| 10/17/2007 | EP1844068A1 Molecules and chimeric molecules thereof |
| 10/17/2007 | EP1844067A2 Novel peptides which interact with anti-apoptotic members of the family of bcl-2 proteins and use thereof |
| 10/17/2007 | EP1844066A1 Motif of beclin protein which interacts with anti-apoptotic members of the family of bcl-2 proteins and use thereof |
| 10/17/2007 | EP1844065A1 Polypeptide having function related to pyridoxine biosynthesis, polynucleotide coding the polypeptide, and those use |
| 10/17/2007 | EP1844064A2 Axmi-018, axmi-020, and axmi-021, a family of delta-endotoxin genes and methods for their use |
| 10/17/2007 | EP1843773A1 Method and composition for treatment of neoplasms |
| 10/17/2007 | EP1644513A4 Assay and kits for detecting protein binding |
| 10/17/2007 | EP1583548A4 Hla-a1, a2 -a3,-a24,-b7,and -b44 tumor associated antigen peptides and compositions |
| 10/17/2007 | EP1578372A4 Ca125 gene and its use for diagnostic and therapeutic interventions |
| 10/17/2007 | EP1572927A4 Enhanced silk exsertion under stress |
| 10/17/2007 | EP1541589B1 Fused protein with the function of both thrombolysis and anticoagulation and the use of it |
| 10/17/2007 | EP1427758B1 Compositions and methods of treating diabetes |
| 10/17/2007 | EP1417487B1 Epitope testing using hla |
| 10/17/2007 | EP1412506B1 Regulation of peroxisomal fatty acid transport in plants |
| 10/17/2007 | EP1311289B1 Vaccines containing ribavirin |
| 10/17/2007 | EP1294892B1 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 10/17/2007 | EP1123387B1 Mn gene and protein |
| 10/17/2007 | EP1123316A4 Protein engineering |
| 10/17/2007 | EP1092018B1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT |
| 10/17/2007 | EP1076710B1 Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 10/17/2007 | EP1002103B1 A human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof |
| 10/17/2007 | CN101056994A Methods for identifying a patient as a candidate for treatment with a long acting beta agonist and for predicting a patient's response to long acting beta 2 agonist therapy by analysing polymorphisms |
| 10/17/2007 | CN101056987A Bioactive compositions, natural methods of producing them and computational methods for designing natural production processes |
| 10/17/2007 | CN101056982A Mutant porcine reproductive and respiratory syndrome virus |
| 10/17/2007 | CN101056890A Deamidated interferon-beta |
| 10/17/2007 | CN101056889A Transcription factors fungi regulon zinc binuclear cluster family |
| 10/17/2007 | CN101056888A Transport protein which is used to introduce chemical compounds into nerve cells |
| 10/17/2007 | CN101056646A Recombinant newcastle disease virus |
| 10/17/2007 | CN101056534A 抗线虫的转基因植物 Transgenic nematode resistance in plants |
| 10/17/2007 | CN101054596A Recombination adenovirus for curing overexpression proto-oncogene neu/erbB2 malignancy |
| 10/17/2007 | CN101054589A Highly efficient cry8F gene for Coleoptera pest, expression protein and application thereof |
| 10/17/2007 | CN101054586A Rice chlorine ion passage gene OsCLC, coding protein and clone method thereof |
| 10/17/2007 | CN101054584A 鱼类干扰素基因及其用途 Fish interferon gene and its use |
| 10/17/2007 | CN101054583A Gene sequence of penaeus monodon cell periodic protein B |
| 10/17/2007 | CN101054582A A-type kreotoxin receptor combination region Hc, coding protein and application thereof |
| 10/17/2007 | CN101054419A Vectors with modified protease-dependent tropism |
| 10/17/2007 | CN101054414A Method of extracting and preparing deer DGF |
| 10/17/2007 | CN101054413A Tumor correlated albumen, coding gene and application thereof |
| 10/17/2007 | CN101054412A Pathogenic gene for far end arthrosis bend, detection method and application thereof |
| 10/17/2007 | CN101054411A Corn calcium adjusting phosphatase B analogy albumen, coding gene and application thereof |
| 10/17/2007 | CN101054410A Antigen epitope III of neutrality B cell of chicken IBDV VP2 protein and application thereof |
| 10/17/2007 | CN101054408A Method for separating housefly secretion type antibacterial peptide, product and application thereof |
| 10/17/2007 | CN101053561A Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesis |
| 10/17/2007 | CN100343671C Method for identifying and extracting endotoxin |
| 10/17/2007 | CN100343282C Hybrid interferon compositions and methods of use |
| 10/17/2007 | CN100343280C CUDR as biomarker for cancer progression and therapeutic response |
| 10/17/2007 | CN100343279C A novel gene OSISAP1 of rice confers tolerance to stresses and a method thereof |
| 10/17/2007 | CN100343229C 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of PPAR-alpha |